Home / Moxonidine / Sweden
SE ATC C02AC05 · updated 2 Nov 2026
Moxonidine shortage in Sweden
Is there a Moxonidine shortage in Sweden?
Yes. As of 2 Nov 2026, 1 Moxonidine product is reported short in Sweden. The company estimate for the return is 28 Feb 2027. Main reason: not stated.
Also short in Norway. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Moxonidin STADA 0,2 mg Blister, 100 tabletter anticipated | STADA Arzneimittel AG | 3 Nov 2026 | 28 Feb 2027 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.